CGON CG Oncology, Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
19:12
Nov 05
seedy19tron
Long CGON on PIVOT setup
Long $cgon after going long big; argues PIVOT’s delayed event trigger and a weak ATLAS control support HR<0.6 and 73% vs 58% 12-month recurrence-free.
CGON CG Oncology, Inc. Long Position: Holding —
22:06
Nov 04
seedy19tron
CGON long on PIVOT trial floor
Goes long big on CGON, arguing PIVOT has a statistical floor: high-grade patients drive roughly 30% of control recurrences, pushing overall HR to 0.75 even if creto does nothing in low-grade disease; any low-grade benefit gets HR below 0.6. Calls HR<0.6 and 73% vs 58% recurrence-free at 12 months, with an 80/20 hit probability.
CGON CG Oncology, Inc. Long 1ST Position: Opened —

About CGON Investor Commentary

Across the available history and selected sources, Buzzberg tracks CGON (CG Oncology, Inc.) across 1 sources: 2 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 25% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 8 total trade ideas tracked. Past 7 days, before deduplication: 2 bullish, 4 other directions. Latest voices: seedy19tron.